$196.39
Price
$29.0B
Market Cap
21.1
P/E Ratio
11.8
Forward P/E
$9.31
EPS (TTM)
—
Dividend Yield
$4.3B
Cash
$6.6B
Total Debt
148M
Shares Out
$121.05
$205.97
52-Week Range
Institutional Ownership of BIOGEN INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Patient Capital Management|Samantha McLemore
|
379.7K | $70M | $188.73 | -7.91% | |
|
Causeway Capital Management|Sarah Ketterer
|
280.8K | $51M | $151.25 | +8.70% | |
|
Hillman Capital Management|Mark Hillman
|
29.5K | $5M | — | — |
Trading Activity for BIOGEN INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| SELL | -34.1% | 379.7K | $70M | $185.32 | |
| SELL | -46.1% | 280.8K | $51M | $185.32 | |
| SELL | -3.2% | 29.5K | $5M | $185.32 | |
| 2025-Q4 | |||||
| BUY | +45.3% | 576.4K | $101M | $164.68 | |
| SELL | -8.2% | 521.1K | $92M | $164.68 | |
| SELL | -20.4% | 30.5K | $5M | $164.68 | |
| 2025-Q3 | |||||
| BUY | +15.0% | 567.5K | $79M | $134.94 | |
| BUY | +23.8% | 396.6K | $56M | $134.94 | |
| SELL | -8.6% | 38.4K | $5M | $134.94 | |
| 2025-Q2 | |||||
| SELL | -29.7% | 320.5K | $40M | $125.59 | |
| BUY | +13.8% | 493.4K | $62M | $125.59 | |
| SELL | -4.7% | 42.0K | $5M | $125.59 | |
| 2025-Q1 | |||||
| BUY | +10.1% | 455.6K | $62M | $142.37 | |
| BUY | +53.9% | 433.5K | $59M | $142.37 | |
| BUY | +2.2% | 44.0K | $6M | $142.37 | |
| 2024-Q4 | |||||
| BUY | +61.7% | 414.0K | $63M | $165.79 | |
| BUY | NEW | 281.7K | $43M | $165.79 | |
| BUY | +22.2% | 43.1K | $7M | $165.79 | |
| 2024-Q3 | |||||
| SELL | -0.5% | 255.9K | $50M | $204.82 | |
| SELL | -1.9% | 35.3K | $7M | $204.82 | |
| 2024-Q2 | |||||
| BUY | +18.1% | 257.3K | $60M | $220.07 | |
| BUY | +0.5% | 36.0K | $8M | $220.07 | |
| 2024-Q1 | |||||
| BUY | NEW | 217.9K | $47M | $227.36 | |
| BUY | +3.8% | 35.8K | $8M | $227.36 | |
| SELL | EXIT | — | — | $227.36 | |
| 2023-Q4 | |||||
| BUY | +0.5% | 34.5K | $9M | $248.13 | |
| 2023-Q3 | |||||
| BUY | +16.6% | 34.3K | $9M | $267.17 | |
| SELL | EXIT | — | — | $267.17 | |
| SELL | -7.3% | 950 | $244160 | $267.17 | |
| 2023-Q2 | |||||
| SELL | -0.4% | 29.4K | $8M | $298.66 | |
| BUY | NEW | 1.6K | $460887 | $298.66 | |
| 2023-Q1 | |||||
| SELL | -1.8% | 29.5K | $8M | $274.01 | |
| 2022-Q4 | |||||
| SELL | -5.3% | 30.1K | $8M | $283.44 | |
| SELL | EXIT | — | — | $283.44 | |
| 2022-Q3 | |||||
| SELL | -26.2% | 31.8K | $8M | $211.84 | |
| 2022-Q2 | |||||
| SELL | EXIT | — | — | $205.23 | |
| BUY | +0.8% | 43.0K | $9M | $205.23 | |
| 2022-Q1 | |||||
| SELL | -1.8% | 843.0K | $178M | $214.59 | |
| BUY | +57.0% | 42.7K | $9M | $214.59 | |
| BUY | NEW | 2.4K | $502000 | $214.59 | |
| 2021-Q4 | |||||
| BUY | NEW | 858.5K | $206M | $261.55 | |
| SELL | -3.9% | 27.2K | $7M | $261.55 | |
| 2021-Q3 | |||||
| SELL | EXIT | — | — | $335.57 | |
| BUY | +3.9% | 28.3K | $8M | $335.57 | |
| 2021-Q2 | |||||
| SELL | EXIT | — | — | $274.68 | |
| SELL | EXIT | — | — | $274.68 | |
| BUY | NEW | 79.5K | $28M | $274.68 | |
| SELL | -0.2% | 27.2K | $9M | $274.68 | |
| 2021-Q1 | |||||
| BUY | NEW | 603.9K | $169M | $269.93 | |
| BUY | +36.9% | 27.3K | $8M | $269.93 | |
| 2020-Q4 | |||||
| BUY | +1.5% | 19.9K | $5M | $248.59 | |
| SELL | EXIT | — | — | $248.59 | |
| 2020-Q3 | |||||
| BUY | +20.9% | 19.6K | $6M | $278.45 | |
| SELL | -11.9% | 2.9K | $810000 | $278.45 | |
| 2020-Q2 | |||||
| SELL | -93.1% | 3.2K | $868000 | $302.73 | |
| SELL | -0.8% | 16.2K | $4M | $302.73 | |
| SELL | EXIT | — | — | $302.73 | |
| 2020-Q1 | |||||
| SELL | -0.8% | 643.0K | $203M | $296.75 | |
| SELL | -5.1% | 47.2K | $15M | $296.75 | |
| SELL | -9.6% | 16.4K | $5M | $296.75 | |
| BUY | NEW | 10.0K | $3M | $296.75 | |
| 2019-Q4 | |||||
| BUY | NEW | 648.4K | $192M | $292.18 | |
| BUY | NEW | 49.7K | $15M | $292.18 | |
| BUY | NEW | 49.7K | $15M | $292.18 | |
| 2019-Q3 | |||||
| BUY | +37.8% | 3.2K | $743000 | $233.23 | |
| 2019-Q2 | |||||
| SELL | -5.4% | 2.3K | $542000 | $230.52 | |
| 2019-Q1 | |||||
| SELL | EXIT | — | — | $326.63 | |
| BUY | +16.4% | 2.5K | $579000 | $326.63 | |
| 2018-Q4 | |||||
| BUY | +13.0% | 2.1K | $634000 | $319.94 | |
| 2018-Q3 | |||||
| BUY | +4.1% | 1.9K | $659000 | $344.21 | |
| 2018-Q2 | |||||
| BUY | +2.5% | 1.8K | $520000 | $280.05 | |
| 2018-Q1 | |||||
| BUY | +87.7% | 1.7K | $478000 | $299.38 | |
Insider Trading for BIOGEN INC
6 Months Insider Sentiment
Buy $0
Sell $0
0
Buys
0
Sells
+0
Net
0
Grants
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 01, 2025 | Christopher Viehbacher | President and CEO | EXERCISE | 7.0K | — | — |